A large % of GBM samples (76%) expressed mild to moderate levels (Log2 > 0 to < 2) of IL-13Rα1, while 28% samples expressed mild to moderate levels of IL-13Rα2 mRNA. The gene discussed is IL13RA2; the disease is glioblastoma.